Prevalence of end-stage kidney disease and distribution of treatment modalities (notice n° 191205)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01896cam a2200205 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250112044547.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Issad, Belkacem |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Prevalence of end-stage kidney disease and distribution of treatment modalities |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2022.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 90 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | To mark twenty years of the REIN (French Renal Epidemiology and Information Network), a summary report on the contributions of the French national end-stage kidney disease (ESKD) registry was produced. On ESKD prevalence, a number of key takeaways were identified. While chronic kidney disease affects all age groups, there are ever more patients requiring treatment in the older age groups, with a median age of 71.1 years (IQR 60.3-80.0) on dialysis and 58.7 years (IQR 47.4-68.3) with a kidney transplant. Despite an increase in transplant activity and improved graft survival, the gap between the number of dialysis patients and transplant patients at the end of each year has only moderately reduced. There has been a moderate decrease in the proportion of in-center hemodialysis, explained by a significant increase in medicalized dialysis units (out-center hemodialysis) and a decrease in self-care hemodialysis. Finally, rates of home-based care have remained stable despite ministerial incentives and the guidelines issued in the SFNDT white paper.© 2022 Société francophone de néphrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved. |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Galland, Roula |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Merle, Véronique |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lobbedez, Thierry |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lassalle, Mathilde |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Néphrologie & Thérapeutique | Volume 18 | Suppl. Issue 2 | 2022-10-26 | p. 25-30 | 1769-7255 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/journal-nephrologie-therapeutique-2022-HS2-page-25?lang=en">https://shs.cairn.info/journal-nephrologie-therapeutique-2022-HS2-page-25?lang=en</a> |
Pas d'exemplaire disponible.
Réseaux sociaux